VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Siwu Tang
Preclinical
Small molecule
S
Singapore General Hospital
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Hypoperfusion
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Hypoperfusion
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Platelet Function
1 trial
Effect of Herbal Products on Platelet Function and Clotting
Completed
·
S
Singapore General Hospital
·
Phase 3
·
NCT02008981
·
75 enrolled
Hypoperfusion
1 trial
Efficiency Study of Siwu Tang to Treat Brain Hypoperfusion Syndrome
Unknown status
·
—
·
N/A
·
NCT01221662
·
80 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Siwu Tang. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Siwu Tang compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Siwu Tang. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Singapore General Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
S
Singapore General Hospital
Related News